The global CAR T-cell therapy market is projected to grow from USD 2.7 billion in 2025 to over USD 27.5 billion by 2033, reflecting a robust CAGR of 26.2%.
Gozellix®, after radiolabeling with 68 Ga, is indicated for PET scanning of PSMA positive lesions in men with prostate cancer who have suspected metastasis and are candidates for initial definitive ...
Newronika, a leader in neuromodulation and adaptive deep brain stimulation (DBS) technology, announced today that it has received CE Mark approval for its ...
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced that new findings from the CLEAR study were presented at the 40th Annual European Association of ...
To further enhance employee well-being, Allstate India recently announced its partnership with Spring Health, a global leader in mental health and wellness solutions. Through this partnership, ...
The investigation focuses on a student athlete, who swam on the school's women's team and was the first openly transgender ...
Accelerate Diagnostics, Inc. , an innovator in rapid in vitro diagnostics for microbiology, today announced the submission of its Accelerate WAVEtm system and positive blood culture gram-negative test ...
Cloudflare, Inc. , the leading connectivity cloud company, has been named by Forrester Research, Inc. as a Leader in The Forrester Wavetm: Web Application Firewall Solutions, Q1 2025 report.
The Manchester Savers has achieved near-mythical status among New Hampshire’s thrift enthusiasts, drawing dedicated shoppers ...
Red light therapy, once limited to high-end clinics and specialized wellness centers, is now more accessible thanks to Mito ...
In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts caution that more research is needed. Gavin Nielsen was 2 years old when ...
Exelixis, Inc. (Nasdaq: EXEL) today announced that the U.S. Food and Drug Administration (FDA) has approved CABOMETYX® (cabozantinib) for the treatment of 1) adult and pediatric patients 12 years of ...